Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
BMJ Open|June 2, 2019
What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in FranceEmmanuel Cognat, François Mouton Liger, Anne-Cécile Troussière, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 18, 2015
Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's diseaseBruno Dubois, Marie Chupin, Harald Hampel, et al.The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Usefulness of Cerebrospinal Fluid Alzheimer's disease biomarkers in older patients: Evidence from a national multicenter prospective studyThéodore Decaix, François Mouton-Liger, Julien Dumurgier, et al.Journal of Alzheimer'S Disease : JAD|April 6, 2012
The French series of autosomal dominant early onset Alzheimer's disease cases: mutation spectrum and cerebrospinal fluid biomarkersDavid Wallon, Stéphane Rousseau, Anne Rovelet-Lecrux, et al.Plos Medicine|March 29, 2017
APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic casesHélène-Marie Lanoiselée, Gaël Nicolas, David Wallon, et al.Journal of Alzheimer'S Disease : JAD|August 6, 2019
Causative Mutations and Genetic Risk Factors in Sporadic Early Onset Alzheimer's Disease Before 51 YearsMorgane Lacour, Olivier Quenez, Anne Rovelet-Lecrux, et al.European Journal of Human Genetics : EJHG|August 6, 2015
Screening of dementia genes by whole-exome sequencing in early-onset Alzheimer disease: input and lessonsGaël Nicolas, David Wallon, Camille Charbonnier, et al.Pageof 3